2[1]The National Institute of Neurological Disorders and Stroke rt-PA storke study Group. (NINDS) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995,333∶1581～7.
3[2]Lyden P.D.Grotta J. C, Levine S, R. et al. Intravenous thrombolysis for acute stroke. Neurology 1997,49∶14～29.
4[3]The Multicentre Acute stroke Trial-Europe Study Group. Thrombolytic therapy wiht streptokinase in acute ischemic stroke. N Engl J Med 1996,333∶145～150.
5[4]Donna GA. Davis SM, Chambers BR, et al. streptokinase for acute ischemin stroke with relationship to time of administration. JAMA 1996,276∶961～966.
6[5]R,Ferrari, C Ceconi, S Curello, et al. Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. Intern J Cardiol 1998,65(suppl.l)S 7～S16.
7[6]Overgaard K. Thromogolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rew 1994 Fall;6(3)∶257～86.
8[7]Bolli R. Mechanism of Myocardial stunning. Circulation 1990,82∶723～38.
5Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke inci- dence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease [ J ]. Stroke, 1995, 26(3) :361 -367.
